免疫疗法
免疫系统
胶质瘤
CD8型
细胞
微卫星不稳定性
计算生物学
生物
癌症研究
免疫学
基因
遗传学
等位基因
微卫星
作者
Nan Zhang,Hao Zhang,Wantao Wu,Ran Zhou,Shuyu Li,Zeyu Wang,Ziyu Dai,Liyang Zhang,Fangkun Liu,Zaoqu Liu,Jian Zhang,Peng Luo,Zhixiong Liu,Quan Cheng
出处
期刊:Theranostics
[Ivyspring International Publisher]
日期:2022-01-01
卷期号:12 (13): 5931-5948
被引量:142
摘要
Rationale: Accumulating evidence demonstrated that long noncoding RNAs (lncRNAs) involved in the regulation of the immune system and displayed a cell-type-specific pattern in immune cell subsets.Given the vital role of tumor-infiltrating lymphocytes in effective immunotherapy, we explored the tumor-infiltrating immune cell-associated lncRNA (TIIClncRNA) in low-grade glioma (LGG), which has never been uncovered yet.Methods: This study utilized a novel computational framework and 10 machine learning algorithms (101 combinations) to screen out TIIClncRNAs by integratively analyzing the sequencing data of purified immune cells, LGG cell lines, and bulk LGG tissues.Results: The established TIIClnc signature based on the 16 most potent TIIClncRNAs could predict outcomes in public datasets and the Xiangya in-house dataset with decent efficiency and showed better performance when compared with 95 published signatures.The TIIClnc signature was strongly correlated to immune characteristics, including microsatellite instability, tumor mutation burden, and interferon γ, and exhibited a more active immunologic process.Furthermore, the TIIClnc signature predicted superior immunotherapy response in multiple datasets across cancer types.Notably, the positive correlation between the TIIClnc signature and CD8, PD-1, and PD-L1 was verified in the Xiangya in-house dataset.Conclusions: The TIIClnc signature enabled a more precise selection of the LGG population who were potential beneficiaries of immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI